首页> 外文会议>Clinical Histocompatibility Workshop. >CASE REPORT: A DONOR-SPECIFIC ANTI-DP ANTIBODY APPARENTLY CAUSING ACUTE ANTIBODY MEDIATED REJECTION IN A KIDNEY RETRANSPLANT RECIPIENT
【24h】

CASE REPORT: A DONOR-SPECIFIC ANTI-DP ANTIBODY APPARENTLY CAUSING ACUTE ANTIBODY MEDIATED REJECTION IN A KIDNEY RETRANSPLANT RECIPIENT

机译:案例报告:一种施主特异性抗DP抗体,显然导致急性抗体介导的肾脏重新筛选受体抑制剂

获取原文

摘要

Although donor-specific anti-DP antibodies have been shown in several case reports (e.g., 1, 2) to be associated with accelerated kidney graft rejection and graft loss, Transplant Centers have continued to perform DP mis-matched transplants for patients known to have DP antibodies for several reasons: Donors are almost never typed for DP by the OPO laboratories; DP alleles cannot be listed in UNOS as unacceptable types; and, patients with DP antibodies usually have so many other HLA antibodies that they might otherwise never receive an opportunity for transplant. Published case reports do indicate that timely treatment for antibody mediated rejection (AMR) can at least prevent graft loss although long-term outcomes are not known. We herein report a case in which a donor-specific anti-DP antibody appeared to cause acute AMR. This event led to a change in our Transplant Center's policies relating to transplant candidates with strong DP antibodies.
机译:虽然已经在几种情况下已经显示了有关供体的抗DP抗体(例如,1,2)与加速的肾移植抑制和接枝损失相关,但移植中心继续对已知患者进行DP错误匹配的移植DP抗体有几个原因:捐助者几乎从未键入OPO实验室的DP; DP等位基因不能作为不可接受的类型列在UNO中;并且,具有DP抗体的患者通常具有如此许多其他HLA抗体,否则它们可能从未收到移植的机会。公布病例报告确实表明,对于抗体介导的排斥(AMR)的及时治疗可以至少预防接枝损失,尽管不知道是长期的结果。我们在本文中报告了一种旨在引起急性AMR的施主特异性抗DP抗体的情况。该事件导致我们的移植中心与具有强大DP抗体的移植候选者有关的策略的变化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号